Search research articles
Contact Us
Filters
Showing results (631-640 of 670) with videos related to
Page
of 67
Sort By:
Plos Pathogens
|
June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
Camille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
Experimental Cell Research
|
April 8, 2006
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation
Aaron N Nguyen, Elizabeth G Stebbins, Margaret Henson, et al.
Cells
|
June 11, 2025
A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-Methyltransferase
Jessica A Wright, Stephanie D White, Gavin Frame, et al.
Journal of the American College of Radiology : JACR
|
March 16, 2026
ACR Appropriateness Criteria® Abdominal Aortic Aneurysm or Dissection-Interventional Planning and Follow-Up: Update 2025
, Daniel P Sheeran, Ricky T Tong, et al.
Neurology
|
September 13, 2022
Characteristics and Gender Differences of Headache in the Veterans Health Administration: A National Cohort Study, Fiscal Year 2008-2019
Jason Jonathon Sico, Elizabeth K Seng, Kaicheng Wang, et al.
The Laryngoscope
|
March 3, 2023
Postoperative Polyp Scale (POPS): Development of a New Sinonasal Polyp Grading Scale
Arthur W Wu, Akaber M Halawi, Elisa A Illing, et al.
Journal of the American College of Radiology : JACR
|
December 1, 2023
ACR Appropriateness Criteria® Dialysis Fistula Malfunction
, Mikhail C S S Higgins, Matthew Diamond, et al.
Neurology
|
September 30, 2010
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2
D M Kay, C F Stevens, T H Hamza, et al.
Pharmacology
|
January 8, 2008
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinase
Bruce Koppelman, Heather K Webb, Satyanarayana Medicherla, et al.
Leukemia
|
April 18, 2006
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo
T A Navas, A N Nguyen, T Hideshima, et al.
Page
of 67
Search research articles
Search
Showing results (631-640 of 670) with videos related to
Sort By:
Page
of 67
Plos Pathogens
|
June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
Camille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
Experimental Cell Research
|
April 8, 2006
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation
Aaron N Nguyen, Elizabeth G Stebbins, Margaret Henson, et al.
Cells
|
June 11, 2025
A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-Methyltransferase
Jessica A Wright, Stephanie D White, Gavin Frame, et al.
Journal of the American College of Radiology : JACR
|
March 16, 2026
ACR Appropriateness Criteria® Abdominal Aortic Aneurysm or Dissection-Interventional Planning and Follow-Up: Update 2025
, Daniel P Sheeran, Ricky T Tong, et al.
Neurology
|
September 13, 2022
Characteristics and Gender Differences of Headache in the Veterans Health Administration: A National Cohort Study, Fiscal Year 2008-2019
Jason Jonathon Sico, Elizabeth K Seng, Kaicheng Wang, et al.
The Laryngoscope
|
March 3, 2023
Postoperative Polyp Scale (POPS): Development of a New Sinonasal Polyp Grading Scale
Arthur W Wu, Akaber M Halawi, Elisa A Illing, et al.
Journal of the American College of Radiology : JACR
|
December 1, 2023
ACR Appropriateness Criteria® Dialysis Fistula Malfunction
, Mikhail C S S Higgins, Matthew Diamond, et al.
Neurology
|
September 30, 2010
A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2
D M Kay, C F Stevens, T H Hamza, et al.
Pharmacology
|
January 8, 2008
Pharmacological properties of SD-282 - an alpha-isoform selective inhibitor for p38 MAP kinase
Bruce Koppelman, Heather K Webb, Satyanarayana Medicherla, et al.
Leukemia
|
April 18, 2006
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo
T A Navas, A N Nguyen, T Hideshima, et al.
Page
of 67